brigatinib: Clinical Trials

2 trials of brigatinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow brigatinib: new trials by email Literature Review of brigatinib trials Research Report on brigatinib

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Brigatinib, Alectinib - ALK+ Advanced NSCLC
Phase 3CompletedTakeda2482019-04-192025-09-12
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants
Brigatinib, Crizotinib - Non-small Cell Lung Cancer, Lung Cancer
Phase 3CompletedAriad Pharmaceuticals2752016-05-262021-08-20

Conditions studied

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Carcinoma, Large Cell (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Lung Neoplasms (1)

Sponsors

Ariad Pharmaceuticals (1)  ·  Takeda (1)

Countries

Austria (2)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Hong Kong (2)  ·  Italy (2)  ·  South Korea (2)  ·  Spain (2)  ·  Sweden (2)  ·  Taiwan (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Chile (1)  ·  China (1)

Results publications

PMID 28501139, PMID 30280657, PMID 32780660, PMID 34423676, PMID 37574132, PMID 39707229, PMID 41410381, PMID 41740899

NIH funding

2015 (1), 2018 (1)